Variance Application - Primo Entertainment Inc
Summary
FDA received a variance application from Primo Entertainment Inc (New York) on March 13, 2026. The application was submitted to the Center for Devices and Radiological Health (CDRH) for review. No associated documents are currently available for public viewing on the regulatory docket.
What changed
Primo Entertainment Inc filed a variance application with FDA's CDRH seeking regulatory exception or waiver for medical device-related operations. Variance applications request flexibility from specific FDA requirements when standard compliance poses practical challenges. The application is currently in the review stage with no determinations or documents publicly available.
Affected parties should monitor this docket for any published application materials, FDA requests for additional information, or decisions on the variance request. Medical device manufacturers seeking similar flexibility may reference this docket as a model for variance submission procedures.
What to do next
- Monitor for updates on the FDA variance application docket
Source document (simplified)
Content
There are no documents available to view or download
Attachments 1
Variance Application from Primo Entertainment Inc
More Information
- Author(s) CDRH
Download
Related changes
Get daily alerts for Regs.gov: Food and Drug Administration
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when Regs.gov: Food and Drug Administration publishes new changes.